Breakthroughs in Ovarian Cancer Treatment & Clinical Trials

In this episode of Teal Talk – An Ovarian Cancer Podcast, Dr. Michael Birrer, a leading expert in ovarian cancer, explains how treatment has progressed from standard chemotherapy to more targeted therapies, molecular testing, and precision medicine designed around each patient’s tumor.

Listeners will learn about bevacizumab, PARP inhibitors, antibody drug conjugates (ADCs), immunotherapy, and why clinical trials are essential for bringing new treatment options forward. The conversation also covers genetic and biomarker testing, family risk, and how to start informed and confident discussions with a care team.

💙 Learn more about ovarian cancer and the National Ovarian Cancer Coalition: ovarian.org 📋 Share your feedback: bit.ly/tealtalksurvey

This podcast is for informational purposes only and does not replace professional medical advice.